E-LIB Suche - Ergebnisse für: Furman, Richard R

1

Tumor mutational load is prognostic for progression to ther..:

Kleinstern, Geffen ; Boddicker, Nicholas J. ; O'Brien, Daniel R....
Blood Advances. 8 (2024) 9 - p. 2118-2129 , 2024

Link: https://doi.org/10.1182/..

2

Cardiovascular events reported in patients with B-cell mali..:

Moslehi, Javid J. ; Furman, Richard R. ; Tam, Constantine S....
Blood Advances. 8 (2024) 10 - p. 2478-2490 , 2024

Link: https://doi.org/10.1182/..

3

Detailed safety profile of acalabrutinib vs ibrutinib in pr..:

Seymour, John F. ; Byrd, John C. ; Ghia, Paolo...
Blood. 142 (2023) 8 - p. 687-699 , 2023

Link: https://doi.org/10.1182/..

4

Hyperphosphorylation of BCL-2 family proteins underlies fun..:

Chong, Stephen Jun Fei ; Zhu, Fen ; Dashevsky, Olga...
Journal of Clinical Investigation. 133 (2023) 22 - p. , 2023

Link: https://doi.org/10.1172/..

5

The immunomodulatory molecule TIGIT is expressed by chronic..:

Arruga, Francesca ; Rubin, Marta ; Papazoglou, Despoina...
Haematologica. 108 (2023) 8 - p. 2101-2115 , 2023

Link: https://doi.org/10.3324/..

6

XPO1 Enables Adaptive Regulation of mRNA Export Required fo..:

Marullo, Rossella ; Rutherford, Sarah C. ; Revuelta, Maria V....
Cancer Research. 84 (2023) 1 - p. 101-117 , 2023

Link: https://doi.org/10.1158/..

7

Nine-year follow-up of lenalidomide plus rituximab as initi..:

Yamshon, Samuel ; Chen, Gui Zhen ; Gribbin, Caitlin...
Blood Advances. 7 (2023) 21 - p. 6579-6588 , 2023

Link: https://doi.org/10.1182/..

8

Bioequivalence and Relative Bioavailability Studies to Asse..:

Sharma, Shringi ; Pepin, Xavier ; Burri, Harini...
Clinical Pharmacology in Drug Development. 11 (2022) 11 - p. 1294-1307 , 2022

Link: https://doi.org/10.1002/..

9

Cardiovascular adverse events in patients with chronic lymp..:

Brown, Jennifer R. ; Byrd, John C. ; Ghia, Paolo...
Haematologica. 107 (2021) 6 - p. 1335-1346 , 2021

Link: https://doi.org/10.3324/..

10

Outcomes in CLL patients with NOTCH1 regulatory pathway mut..:

Helbig, Daniel R. ; Abu‐Zeinah, Ghaith ; Bhavsar, Erica...
American Journal of Hematology. 96 (2021) 6 - p. , 2021

Link: https://doi.org/10.1002/..

11

Poster: CLL-115: First Results of a Head-to-Head Trial of A..:

Byrd, John C. ; Hillmen, Peter ; Ghia, Paolo...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S220 , 2021

Link: https://doi.org/10.1016/..

12

Poster: CLL-354: Pooled Analysis of Cardiovascular Events f..:

Ferrajoli, Alessandra ; Byrd, John C. ; Ghia, Paolo...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S220 , 2021

Link: https://doi.org/10.1016/..

13

CLL-115: First Results of a Head-to-Head Trial of Acalabrut..:

Byrd, John C. ; Hillmen, Peter ; Ghia, Paolo...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S318 , 2021

Link: https://doi.org/10.1016/..

14

Monitoring and Managing BTK Inhibitor Treatment-Related Adv..:

O'Brien, Susan M. ; Brown, Jennifer R. ; Byrd, John C....
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

Phase Ib dose-escalation study of the selective, non-covale..:

Allan, John N. ; Pinilla-Ibarz, Javier ; Gladstone, Douglas E....
Haematologica. 107 (2021) 4 - p. 984-987 , 2021

Link: https://doi.org/10.3324/..